Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rang in aandelen #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aandeelprijs
$37.45
Marktkapitalisatie
$166.43B
Verandering (1 dag)
-2.55%
Verandering (1 jaar)
-53.09%
Land
DK
Handel Novo Nordisk A/S (NVO)

Categorie

Aandelsplitsingen voor Novo Nordisk A/S (NVO)
Het aandeel Novo Nordisk A/S (symbool: NVO) heeft in totaal 2 splitsingen ondergaan.
De meest recente splitsing vond plaats op Sep 13, 2023.
Eén aandeel NVO dat vóór Jan 02, 2014 werd gekocht, staat nu gelijk aan 10 aandelen NVO.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2023-09-13 2:1 x2 x10
2014-01-02 5:1 x5 x5
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x2
US
0 -
US
0 -
BE
1 x3
AU
0 -
NL